Research progress of immune checkpoint inhibitor related autoimmune hypophysitis

Research progress of immune checkpoint inhibitor related autoimmune hypophysitis

Immunotherapy induced hypophysitis (IH) has been demonstrated an autoimmune adverse effect of immune checkpoint inhibitors treatment of malignant tumors. The incidence of IH depends on types of immunotherapeutic agents. Patients with IH often present non-specific symptoms, ACTH, TSH and gonadotrophi...

Full description

Bibliographic Details
Main Author:	LI Jia-yi, XING Bing
Format:	Article
Language:	zho
Published:	Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2020-03-01
Series:	Jichu yixue yu linchuang
Subjects:	immune checkpoint inhibitor\|autoimmune hypophysitis\|immune related adverse events
Online Access:	http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/a190570.pdf

Similar Items

Ipilimumab (Immune Checkpoint Inhibitors) Hypophysitis
by: Margot Stagnetto, et al.
Published: (2020-11-01)

Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis
by: Sahityasri Thapi, et al.
Published: (2019-09-01)

Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review
by: Sara Menotti, et al.
Published: (2023-07-01)

Exploring a Rarity: Incidence of and Therapeutic Approaches for Neurological Complications and Hypophysitis in Cancer Patients on Immune Checkpoint Inhibitors—A Single-Center Study
by: Anna Lea Amylidi, et al.
Published: (2023-12-01)

Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis
by: Anna Galligan, et al.
Published: (2023-11-01)

Early Serum Markers for Immune Checkpoint Inhibitor Induced Hypophysitis in Melanoma Patients
by: Fouad Mitri, et al.
Published: (2024-03-01)

Progress in Diagnosis and Treatment of Autoimmune Hypophysitis
by: ZHAI Xiao, et al.
Published: (2022-01-01)

Progress and Challenges of Immune Checkpoint Inhibitor-Induced Hypophysitis
by: Piaohong Chen, et al.
Published: (2023-05-01)

Nivolumab Combined With Ipilimumab Treatment Induced Hypophysitis and Immune-Mediated Liver Injury in Advanced Esophageal Squamous Cell Carcinoma: A Case Report
by: Yi Feng, et al.
Published: (2022-04-01)

Immune-related endocrine disorders in novel immune checkpoint inhibition therapy
by: Le Min
Published: (2016-12-01)

Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature
by: Yining Gao, et al.
Published: (2022-06-01)

Hematological and Extra-Hematological Autoimmune Complications after Checkpoint Inhibitors
by: Bruno Fattizzo, et al.
Published: (2022-04-01)

Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report
by: Fumi Kikuchi, et al.
Published: (2021-04-01)

Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists
by: Irena Druce, et al.
Published: (2022-07-01)

Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside
by: Antonio G. Solimando, et al.
Published: (2020-04-01)

An unsuspected complication with immune checkpoint blockade: a case report
by: Lucia Carril-Ajuria, et al.
Published: (2018-09-01)

Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: a systematic review and meta-analysis
by: Xin Liu, et al.
Published: (2024-04-01)

Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study
by: Saara Kuusisalo, et al.
Published: (2022-05-01)

Recent Advance in Biomarkers for Predicting Immune-related Adverse Events Caused by Immune Checkpoint Inhibitors
by: LI Ying, et al.
Published: (2021-04-01)

IMMUNE CHECKPOINT INHIBITORS AND RHEUMATIC ADVERSE EVENTS
by: Ioana Cretu, et al.
Published: (2018-12-01)

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events
by: Leonie Müller-Jensen, et al.
Published: (2023-02-01)

Rheumatic Immune-related Adverse Events and Treatment of Immune Checkpoint Inhibitors
by: ZHANG Xue, et al.
Published: (2020-11-01)

Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events
by: Junling ZHUANG, et al.
Published: (2019-10-01)

Dermatological Autoimmune Considerations of Immune Checkpoint Therapy
by: Lauren S. Fane, et al.
Published: (2022-09-01)

Progress in Application of TNF-α Inhibitors in Immune Checkpoint Therapy
by: ZHAO Jianrong, et al.
Published: (2021-04-01)

Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases
by: Pankti Reid, et al.
Published: (2023-12-01)

Dataset for: Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune-related adverse events
by: Leonie Müller-Jensen, et al.
Published: (2024-04-01)

Body mass index as a possible predictor of the development of endocrine immune-mediated adverse events during immune checkpoint inhibitors therapy
by: A. A. Glibka, et al.
Published: (2024-04-01)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
by: Junling Zhuang, et al.
Published: (2020-03-01)

A case of severe acute hemorrhagic duodenitis after administration of immune checkpoint inhibitor
by: Keita Saito, et al.
Published: (2022-04-01)

Safety of Immune Checkpoint Inhibitor Resumption after Interruption for Immune-Related Adverse Events, a Narrative Review
by: Marion Allouchery, et al.
Published: (2022-02-01)

Safety of Immune Checkpoint Blockade in Patients with Cancer and Preexisting Autoimmune Diseases and/or Chronic Inflammatory Disorders
by: Mohsin Shah, et al.
Published: (2019-07-01)

Immune checkpoint inhibitor‐associated pituitary‐adrenal dysfunction: A systematic review and meta‐analysis
by: Jingli Lu, et al.
Published: (2019-12-01)

Clinical Observation of Adverse Events of Immune Checkpoint Inhibitors in 20 Advanced Tumor Patients and Literature Reviews
by: WANG Xue, et al.
Published: (2020-06-01)

Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors
by: Liyan Zhang, et al.
Published: (2021-01-01)

Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis
by: Qi Cai, et al.
Published: (2022-12-01)

Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study
by: E. V. Poddubskaya, et al.
Published: (2019-12-01)

Clinical Diagnosis and Treatment of Immune-related Adverse Events in Digestive System Related to Immune Checkpoint Inhibitors
by: Yue LI, et al.
Published: (2019-10-01)

Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy
by: Anca Bobircă, et al.
Published: (2021-06-01)

Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction
by: Lian Duan, et al.
Published: (2020-04-01)